Safeguards needed for tissue donors

Safeguards needed for tissue donors
Tom Tomlinson, Michigan State University, argues that donors to biobanks have a right to information about how their sample may be used. Credit: Photo by G.L. Kohuth.

vast collections of human tissue samples that scientists hope will lead to new treatments for diseases – have a right to basic information about how their donations may be used, a Michigan State University ethicist argues in a new paper.

The idea behind biobanks is that a repository with hundreds of thousands of samples, each linked to and other , can yield discoveries smaller data sets can't match. Once samples are collected, researchers in many fields can use the data repeatedly.

"More and larger biobanks are in many ways the future of ," said Tom Tomlinson, director of MSU's Center for Ethics and Humanities in the Life Sciences. "Their rise as a means that sooner or later – probably sooner – all of us will be participating in research that we know nothing whatsoever about."

have typically viewed biobank donations through the lens of risk: Once someone has given a tissue sample and all identifying information is removed, later research risks no harm to them. Since they no longer need protection, donors usually sign blanket consent forms and receive no updates about how the tissue is used.

But people make donations in the hope of doing good, giving them an ongoing moral stake in what happens to their tissue samples, Tomlinson writes in the Hastings Center Report, a leading bioethics journal.

"Donors should have the information they need to decide if there are moral risks involved that might not be worth taking," he said.

For instance, surveys have found that some people may not donate to publicly funded biobanks if the research would lead to private commercial gain. Others may not want to be involved in research on controversial issues like , or studies that reinforce negative .

"It's hard to tell a person exactly how their donation will be used," Tomlinson said, "but what you can tell them is the range of uses to which it might be put."

Tomlinson offers specific steps biobanks should take to protect donors' rights. Among them:

  • Donors should get ongoing summaries of research projects, written in plain language.
  • Biobanks should inform donors when their tissue might be used in potentially controversial research.
  • Data-management systems should be in place to let donors withdraw their samples at any time if they take issue with the kinds of research the biobank supports.

add to favorites email to friend print save as pdf

Related Stories

Europe tackles ethics of biobanks

Jun 20, 2012

Collections of human biological samples used in medical research should be governed by clear rules that safeguard ethics while advancing knowledge, scientists said Wednesday at a Council of Europe symposium.

Public prefers limited informed consent process for biobanks

Jun 29, 2011

Biobanks are repositories for tissue samples, usually in the form of blood or saliva or leftover tissue from surgical procedures. These samples are collected and used for future research, including genetic research. They ...

Keeping DNA 'all in the family'

Oct 06, 2009

Scientists look for clues about therapies and cures for life-threatening childhood illnesses in children's DNA -- it seems only logical to do so. But the decision as to who should have access to DNA samples from children ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

14 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

18 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...